why choose us

First received: February 02, 2024

Clinical Trial: Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Schizophrenia

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single Dose, Parallel Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TV-44749, Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use, in Chi

Brief Summary: Primary Objective:To evaluate the safety and tolerability of single doses of TV-44749 for subcutaneous (sc) use in Chinese participants with schizophrenia.Secondary Objectives:To evaluate the pharmacokinetics (PK) of single doses of TV-44749 administered sc.To evaluate the pharmacokinetics of oral olanzapine tablets following multiple dose administration.To monitor the safety and tolerability of multiple doses of oral olanzapine tablets given in the study.

Read more